Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
GI InsightsNavigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Diabetes and COVID-19: New Findings on the Systemic Burden
Clinician's RoundtableDiabetes and COVID-19: New Findings on the Systemic Burden
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
ACC Action CenterSemaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
Heart MattersSBP target of lower than 120 mmHg reduces risk of CV events in T2DM
Balancing Blood Sugar: The Role of Yoga in Diabetes Management
What Your Patients Are Talking AboutBalancing Blood Sugar: The Role of Yoga in Diabetes Management
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
NeuroFrontiersEvaluating Endocrine Complications in DMD Patients: Findings from a Survey
- advertisement
Bridging the Gap: Lipid Management in ASCVD Patients with Diabetes to Reduce CV Risk
Medical Industry FeatureBridging the Gap: Lipid Management in ASCVD Patients with Diabetes to Reduce CV Risk
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
- advertisement